Results 1 to 10 of about 652,724 (310)

Maintenance Therapy in AML [PDF]

Frontiers in Oncology, 2021
Recent advances in therapeutics coupled with steady improvements in supportive care for patients with acute myeloid leukemia (AML) have led to improved outcomes.
Patrick K. Reville, Tapan M. Kadia
doaj   +5 more sources

Maintenance therapy after first‐line therapy for ovarian cancer: Quantitative effectiveness [PDF]

Ca-A Cancer Journal for Clinicians
Susana M Campos, Jessica Disilvestro, Stephanie V Blank   +2 more
exaly   +2 more sources

Bridging to transplant and post-transplant maintenance therapy with FLT3 inhibitors in patients with relapsed or refractory FLT3 mutated acute myeloid leukemia

Hematology, 2023
Objectives and Methods This single-center retrospective study was performed to evaluate the safety and efficacy of FMS-like tyrosine kinase 3 (FLT3) inhibitors before and after allogeneic hematopoietic cell transplantation (HCT) in relapsed/refractory ...
Natsuki Hirose, Takayoshi Tachibana, Akihiko Izumi, Shuku Sato, Noriyuki Tadera, Yotaro Tamai, Heiwa Kanamori, Masatsugu Tanaka, Hideaki Nakajima   +8 more
doaj   +1 more source

Experience of pemetrexed in maintenance therapy for metastatic lung adenocarcinoma

Южно-Российский онкологический журнал, 2021
Lung cancer is among the most common malignant diseases in Russia. In 80–90%, its morphological type is nonsmall cell lung cancer. Stage IV primary advanced lung cancer is diagnosed in 41% of patients.
L. Yu. Vladimirova, A. E. Storozhakova, E. A. Kalabanova, P. N. Meshcheryakov, S. V. Oskin, S. N. Kabanov, N. Yu. Samaneva, Ya. V. Svetitskaya, A. V. Tishina   +8 more
doaj   +1 more source

Methadone substitution therapy: Diagnostic challenges in the general practice [PDF]

Opšta Medicina, 2021
Introduction. Opioid addiction is a chronic condition related to different morbidities. The methadone substitution therapy of the opioid addict, combined with social, health, and psychological services is a gold standard of the treatment.
Knežević Snežana B., Dugalić Branimir D., Dugalić Anđelka S.   +2 more
doaj   +1 more source

Safety Profile of Niraparib as Maintenance Therapy for Ovarian Cancer: A Systematic Review and Meta-Analysis

Current Oncology, 2022
Background: Patients with epithelial ovarian cancer (EOC), treated with niraparib maintenance, present with haematological and gastrointestinal toxicities. Limited data exist on niraparib safety assessment. Objective: To evaluate niraparib safety profile,
Antonia Pagkali, Ioannis Mamais, Adamantios Michalinos, Aris P. Agouridis   +3 more
doaj   +1 more source

Maintenance Therapy in Multiple Myeloma [PDF]

Leukemia, 2007
Therapeutic advances in the treatment of multiple myeloma have significantly improved remission duration and overall survival (OS). These strategies have included the use of immunotherapy (interferon), novel agents (bortezomib, thalidomide, and lenalidomide), corticosteroids, and chemotherapy.
R, Mihelic, J L, Kaufman, S, Lonial
openaire   +2 more sources

Case Report: Multifocal EBV-Associated Diffuse Large B-Cell Lymphoma in a Patient With 6-MP Associated Lymphopenia With TPMT Deficiency

Frontiers in Pediatrics, 2022
IntroductionEBV associated lymphoproliferative disorders (EBV LPD) are a known complication following solid organ or hematopoietic stem cell transplantation.
Lara Müller-Scholden, Frank Deinlein, Matthias Eyrich, Paul Gerhardt Schlegel, Verena Wiegering, Matthias Wölfl   +5 more
doaj   +1 more source

Immunomodulators in Maintenance Therapy of Tuberculosis With Its Patomorphosis Features Taken Into Consideration

Антибиотики и Химиотерапия, 2020
One of the fundamental features of tuberculosis pathomorphism in modern conditions is secondary immune deficiency, which manifests itself at the initial stage of the infection process and aggravates as the disease progresses.
V. M. Kolomiets, A. L. Kovalenko, E. V. Talikova   +2 more
doaj   +1 more source

Effect of Lenalidomide Maintenance in Chronic Lymphocytic Leukemia: A Meta-Analysis and Trial-Sequential Analysis

Current Oncology, 2022
Chronic lymphocytic leukemia (CLL) is the most common lymphoproliferative disease in adults. Despite durable responses and sustained remission rates to frontline therapy, CLL is still incurable within standard therapy and eventually relapses. Maintenance
Tsung-Ying Yu, Hong-Jie Jhou, Po-Huang Chen, Cho-Hao Lee   +3 more
doaj   +1 more source